Chronotherapy: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

15 May 2024

  • curprev 15:0215:02, 15 May 2024‎ Lazy talk contribs‎ 1,591 bytes +8‎ No edit summary
  • curprev 15:0115:01, 15 May 2024‎ Lazy talk contribs‎ 1,583 bytes +1,583‎ Created page with "{{TreatmentInfo |drug_name=Chronotherapy with Temozolomide (TMZ) |FDA_approval=Yes (as part of standard glioblastoma treatment) |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Research ongoing |common_side_effects=Increased side effects when administered in the morning; however, these are generally manageable with other therapies. |OS_without=Around 19.5 months for patients with MGMT methylated tumors. |OS_with=Up to 17 months for general cases, and up to 2..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Chronotherapy"